Patricia Andrade‐Gordon
Papers
2
Total Citations
50
H-Index
2
About
Patricia Andrade‐Gordon is a pioneer in the development of high-throughput functional genomics technologies, with a career dedicated to bridging the gap between gene discovery and therapeutic validation. Her key research areas include RNA interference (RNAi)-based target validation and automated quantitative gene expression profiling for drug discovery. She made major contributions by establishing robust, scalable methods that transformed how researchers validate gene function and measure mRNA expression in high-throughput screening environments. Notably, her 2004 paper on high-throughput siRNA-based functional target validation (33 citations) laid critical groundwork for systematic loss-of-function studies, while her companion work on automated TaqMan RT-PCR (17 citations) introduced a novel, fully integrated system using the Allegro platform to streamline sample tracking and liquid handling. These innovations enabled more reliable and efficient gene expression analysis, directly impacting the pharmaceutical industry’s ability to identify and prioritize drug targets. Andrade‐Gordon’s work exemplifies the power of combining engineering precision with molecular biology, making her a respected figure in translational genomics and assay development.
Research Focus
Key Achievements
Top Papers
- 1High-Throughput siRNA-Based Functional Target Validation33 citations · 2004
- 2Gene Expression Analysis for High Throughput Screening Applications17 citations · 2004